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Multiple Endocrine Neoplasia lype 2A: A Northern Ireland and
Australian Fainily
David R. Hadden,* Fergus O'Reilly, Laurence Kennedy, and Colin Russell

A Northern Ireland/Australian family with mulliple endocrine neoplasia type 2A is described. Three
members ofthe first generation studied have died, two men (aged 35 and 51) as a resuh of metastatic
medullary thyroid carcinoma and one woman (the index case, aged 50) due to hypertensive
complications during thyroidectomy from an undiagnosed pheochromocytoma. All members ofthis
familyfound by screening to have either medullary thyroid carcinoma or pheochromocytoma, or both,
have been asymptomatic for their disease. (Henry Ford Hosp MedJ 1987;35:107-9)

M

edullary thyroid carcinoma (MTC) in association with
pheochromocytoma was first described by Sipple (1), although earlier cases have been identified retrospectively (2). The
hereditary nature was recognized by Cushman (3), and many
families have since been described (4-6), including the families reported at the First International Workshop on Multiple
Endocrine Neoplasia Type 2 (MEN-2) Syndromes in 1984, t A l l
reports are consistent with autosomal dominant inheritance with
a high degree of penetrance. The age of presentation varies, and
Ponder (7) has suggested that some individuals who inherit the
gene will not present clinically with thyroid tumors until a late
age. A l l members of these families are therefore at risk and
screening is essential.
The G-kindred have been living in County Antrim, Northem
Ireland, for many generations. Several members emigrated to
Australia in their youth. The occurrence of several cases of MTC
and pheochromocytoma over a period of years, and the chance
meeting of surgical colleagues, brought the familial nature
of the condition to light, although the separate branches of the
family had not connected their problems over the years.
The initial screening procedure used in this study was measurement of basal unstimulated plasma calcitonin (CT) and 24hour urinary catecholamines, followed by adrenal computed
tomography and "'I-meta-iodo-benzylguanidine (MIBG) imaging in several members. The pedigree is shown in the Figure.

Case Reports

Autopsy showed multifocal MTC without secondary deposits and a
right adrenal pheochromocytoma. No abnormality was noted in the left
adrenal gland.
Case II-2
A 61-year-old man was found on clinical screening of relatives of
case 111-3 to have a palpable thyroid gland. Plasma CT was 31,0 jxg/L
(normal < 0,08 |xg/L), His blood pressure was normal, but 24-hour urinary catecholamines showed the adrenaline fraction to be elevated on
several occasions, the highest level being 213 nmol/24 hours (adult
range 3 to 109 nmol), '-"I-MIBG imaging showed bilateral adrenal
tumors, although adrenal computed tomography results were inconclusive. Bilateral adrenalectomy was performed and at least two
separate pheochromocytomas were identified in the right adrenal gland
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The ages of the patients in the following case reports are from
1981 unless otherwise stated.
Case I I - l
The index case of the kindred is a 50-year-old woman who was admitted to her local hospital in 1972 for surgical removal of a solitary
thyroid nodule. Plasma CT was not measured. During surgery she became acutely hypertensive and developed cardiac dysrhythmias. Immediately postoperatively, cardiac arrest occurred and the patient died.
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Figure—The Northern Ireland/Australian kindred.
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and a number of small tumor nodules in the left adrenal gland. Three
months later, total thyroidectomy was perfonned and bilateral nodules
of multifocal MTC were identified.

Case II-3
This man was one of three brothers who had emigrated from Northem Ireland to Australia, He died in Adelaide in 1960, at the age of 36,
Limited autopsy was performed and while no official report is available,
his brother remembers that the doctor was "very interested in his thyroid" (personal communication, Mr, A,J. Edis), It is probable that he
had MTC; he may also have had a pheochromocytoma.

Case III-8
A 34-year-old man was found on screening to have an elevated basal
plasma CT level (13.6 |xg/L). On examination he had a firm nodular thyroid gland. His blood pressure was normal, and 24-hour urinary catecholamines were in the normal adult range. '""I-MIBG scanning of the
adrenal medulla was consistent with bilateral hyperplasia, and computed tomography showed bilateral nodules. Bilateral adrenalectomy
was performed and the presence of multifocal pheochromocytomas
confirmed. Subsequent total thyroidectomy confirmed the presence
of MTC.

Case III-14
Case II-4
This patient was a 57-year-old man, who was another of the three
brothers who had emigrated to Australia. When his younger brother was
diagnosed as having MTC, he was found to have a high basal CT level
which increased on calcium infusion. He also had an elevated plasma
parathyroid hormone without significant hypercalcemia. Total thyroidectomy was performed in 1981, and histology confinned multiple
foci of MTC, with a metastatic deposit in the paratracheal region (personal communication, Mr. A.J. Edis).
Case II-5
This patient, the youngest of three brothers who emigrated to Australia, was a 50-year-old man who at thyroidectomy in 1981 was found
to have undifferentiated MTC (personal communication, Mr. A.J.
Edis). Metastases were disseminated throughout his skeleton, and he
subsequendy died.
Case III-3
A 35-year-old woman was found on clinical examination to have a
large multinodular firm goiter. Basal plasma CT was 67.8 jJig/L. Her
blood pressure was normal, and 24-hour urinary catecholamine levels
were not elevated. Total thyroidectomy was performed and the diagnosis of MTC confirmed. Five months postoperatively, plasma CT
dropped to an undetectable level (< 0.08 (xg/L).

Case III-6
A 29-year-old woman was found on clinical examination to have a
small smooth goiter. Basal plasma CT was 20,9 M-g/L; ""technefium thyroid scan showed one small "cold" area in each lobe ofthe thyroid, and
computed tomography showed defects in the lower pole of each lobe of
the thyroid. Total thyroidectomy was performed and multiple tumor
nodules of MTC were found. Three months postoperatively,
the plasma CT had dropped to < 0.08 p-g/L. Her blood pressure was
normal, and basal urinary catecholamine levels were not elevated.
Clonidine stimulation test results were normal and '^'I-MIBG was
negative. The initial adrenal computed tomography showed a small
nodule in the left adrenal, and she subsequently had successful removal
of bilateral pheochromocytomas.
Case III-7
A 25-year-old man had a barely palpable thyroid gland and no
clinical symptoms. Basal plasma CT was 0.71 p-g/L, which remained
elevated on subsequent measurement. He was at first unwilling to have
neck surgery. Computed tomography of the adrenals subsequendy
showed bilateral nodules consistent with pheochromocytomas, although plasma and urinary catecholamine levels were normal. Adrenal
and thyroid surgery is planned.
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A 22-year-oId man was found on screening to have a marginally elevated basal plasma CT level (0.62 |xg/L). Clinically he was euthyroid,
and the thyroid gland was barely palpable. His blood pressure was normal, 24-hour urinary catecholamine levels were not elevated, and computed tomography ofthe adrenals was normal. Total thyroidectomy was
(jerformed, and histological examinafion showed the presence of multiple tumor nodules of MTC.
Normal unstimulated levels of plasma CT have been found in several
other family members (cases I I l - l , III-5, III-9, and III-13, and IV-1,
IV-2, IV-3, and IV-11). These family members are mainly young children, and the use of pentagastrin-stimulaUon tests in addition to annual
unstimulated screening will be kept carefully under consideration, as
discussed in several other papers presented at this workshop.
Marginally elevated plasma CT levels (unstimulated) have been
found in cases III-2, III-15, IV-4, IV-5, and IV-6. These members will
be kept under observation, although the problems of surveillance and
compliance are well recognized and the optimum fime for surgical
intervention remains uncertain. No further investigations for pheochromocytoma have been undertaken to date.
Patients III-10 and III-l 1 were both found on screening to have MTC
and have had total thyroidectomy (personal communication, Mr. A.J.
Edis). Patient III-IO also had a 1.2cm adenoma ofthe right inferior parathyroid gland, with biochemical evidence of mild hyperparathyroidism. Patient 11-6 had removal of a thyroid tumor in 1961 which has
retrospectively been reclassified as MTC. She remains well.

Discussion
Many aspects of the screening, diagnosis, and management
of patients with this syndrome, and the management of other
family members, were discussed at the Second International
Workshop on MEN-2. Between 1965 and 1978,14 cases of MTC
were diagnosed histologically in Northem Ireland (population
1.5 million). Only one of these was a member of this family, and
she was the index case who had died of the unrecognized
pheochromocytoma (8).
While it is essential that each person in a kindred be seen and
investigated as a private individual, the possession of an inherited trait involves discussion of known disease and treatments in
other relatives. This is more difficult in a relatively close-knit
community than when family members are widely scattered.
We attempted to bring together many of the members of this
kindred for counseling and screening on the same day, but
quickly found that this was inadvisable, not only because of various family interactions but also because of the reasonable desire
for personal discussion.
Although the risk of death from MTC and the effect of early
detection and early thyroidectomy are both becoming better cat-
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egorized (9), in the MEN-2 syndromes pheochromocytoma may
actually produce a greater risk of death, especially in young
adulthood and in childbirth (10). Three of our cases (11-2, III-6,
and III-8), despite the presence of bilateral pheochromocytomas, had normal pressures and were asymptomatic without
elevation of urinary catecholamines. Hereditary pheochromocytomas appear unique in this respect (11). Data from
families studied in The Netherlands (6) showed that the chance
is very small that a MEN-2A patient with a pheochromocytoma
will die as a result of a malignant change with metastases of this
tumor. However, the devastating metabolic effects of an undiagnosed and untreated pheochromocytoma, as shown by the index
case and the similar experience of others (4), has led us to adopt
a radical surgical approach to the adrenal gland, van Heerden et
al (12) favor bilateral adrenalectomy in patients with elevated
catecholamines even if only one adrenal gland is affected macroscopically. Others take a more conservative approach (13).
Symptoms of headache, inappropriate or excessive sweating,
or palpitations with associated hypertension are rarely manifest
(as in this family), and therefore some form of screening
is mandatory.
The natural history of pheochromocytoma is difficult to document, and diagnosis is often precipitate (14), The traditional
screening test of 24-hour urinary catecholamine levels may not
be of any use in the early stages when secretion may be intermittent. MTC itself may even be the best marker for these hereditary pheochromocytomas. Adrenal venous sampling is highly
selective but invasive, and has largely been superseded by computed tomography. The use of '^'I-MIBG to identify these tumors is more helpful in the established case (15), particularly if
metastases are suspected (16). A submaximal exercise test may
tum out to be a useful screening procedure with measurement of
plasma catecholamines (10), but the long survival of some members of our kindred with known pheochromocytoma suggests
that in some cases these adrenal tumors may be inactive during
normal life. The stress of anesthesia, surgery, or childbirth is
well known to activate a previously slumbering pheochromocytoma, as observed with the death of our index case and probably the unexplained sudden death during operation of Case II-3.

Acknowledgments
We are grateful to our colleagues for assistance in the detection, diagnosis, and management of these patients. In particular,

Henry Ford Hosp Med J—Vol 35, Nos 2 & 3, 1987

Dr. R.B. Wilson and Dr. J. Johnston, whose family practices
many of the kindred attend, have been consistently helpful in
dealing with these complex investigations. We are also indebted
to Mr, A,J, Edis, Consultant Surgeon, Royal Perth Hospital,
Australia, for details of the Australian members of the family.

References
1, Sipple GH, The association of pheochromocytonfia with carcinoma of the
thyroid gland, AmJMed 1961;31:163-6,
2, Williams ED, Pollock DJ, Multiple mucosal neuromata with endocrine
tumors: A syndrome allied to von Recklinghausen's disease, J Pathol
1966;91:71-80,
3, Cushman P Jr Familial endocrine tumors: Report of two unrelated kindred
affected with pheochromocytomas, one also with multiple thyroid carcinomas,
AmJMed 1962;32:352-60,
4, Beaugie JM, Belchetz PE, Brown CL, Frankel RJ, Lloyd MH, Report of
a family with inherited medullary carcinoma of the thyroid and pheochromocytoma, Br J Surg 1975;62:264-8,
5, Telenius-Berg M, Diagnostic studies in medullary carcinoma of the thyroid: New methods for early diagnosis in families with Sipple's syndrome. Acta
Med Scand [Suppl] 1977;597:7-60,
6, Lips CJM, Minder WH, Leo JR, Alleman A, Hackeng WHL, Evidence
of multicentric origin of the multiple endocrine neoplasia syndrome type 2A
(Sipple's syndrome) in a large family in The Netherlands: Diagnostic and
therapeutic implications, AmJ Med 1978;64:569-78,
7, Ponder BAJ, Screening for familial medullary thyroid carcinoma: A
review, J R Soc Med 1984;77:585-94,
8, Russell C, Medullary carcinoma of the thyroid gland, Ulster Med J
1980;49:54-64,
9, Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the
thyroid: A study of the clinical features and prognostic factors in 161 patients.
Medicine 1984;63:319-42,
10, Telenius-Berg M, Berg B, Hamberger B, Tibblin S, Screening for early
asymptomatic pheochromocytoma in MEN-2, Henry Ford Hosp Med J
1987;35;110-4,
11, Bravo EL, Gifford RW Jr, Pheochromocytoma: Diagnosis, localization
and management, N Engl J Med 1984;311:1298-1303,
12, van Heerden JA, Sizemore GW, Carney JA, Grant CS, ReMine WH,
Sheps SG, Surgical management of the adrenal glands in the multiple endocrine
neoplasia type II syndrome. World J Surg 1984;8:612-21,
13, Libroia A, Cremoncini C, Valente C, et al, Preliminary report of a kindred
affected from MEN-IIA, J Endocrinol Invest 1984;7:513-6,
14, Modlin IM, Famdon JR, Shepherd A, et al, Phaeochromocytomas in 72
patients: Clinical and diagnostic features, treatment and long term results, Br J
Surg 1979;66:456-65,
15, Sisson JC, FragerMS, ValkTW, et al. Scintigraphic localization of pheochromocytoma, N Engl J Med 1981;305:12-7,
16, Stewart RJ, Anderson JR, Laird JD, Atkinson AB, Kennedy TL, Metaiodobenzylguanidine in metastatic pheochromocytoma, Clin Endocrinol
1984;21:525-7,

Northem Ireland/Australian MEN-2A—Hadden et £

109

